Pfizer bought Global Blood Therapeutics Global Blood Therapeutics from 10/5/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Pfizer completed its acquisition of Global Blood Therapeutics for $5.4, or $68.5 per share.

Global Blood Therapeutics

Review

Source:

{source} pictogram

investors.pfizer.com

Vladimir Petenev

News editor

Write your comment first

News feed

Polyus reported for 2023 by IFRS

2/29/24 PLZL

will build in the Murmansk region 90 thousand square meters of housing

2/29/24 SMLT

MS-21 deliveries will start not earlier than 2025

2/29/24 UNAC

Inter RAO consolidated 100% of Kashirskaya GRES

2/29/24 IRAO

Inter RAO acquired two energy sales companies

2/29/24 IRAO

TMK reported for 2023 by IFRS

2/29/24 TRMK

Inter RAO reported for 2023 by IFRS

2/29/24 IRAO

Europlan reported for 2023 by IFRS

2/29/24 LEAS

Europlan reported for 2023 by IFRS

2/29/24 SFIN

Rosgosstrakh reported for 2023 by RAS

2/29/24 RGSS